Postinduction HypotensionDrugPhase 4
What this study is
This study aims to determine whether a standardized, weight-based crystalloid fluid bolus administered preoperatively reduces the incidence of postinduction hypotension (PIH) in patients undergoing cystoscopy.
What's being tested
- Lactated Ringers
Intervention · DRUG
A bolus of Lactated Ringers (15mL/kg of ideal body weight) will be given to patients prior to anesthesia induction.
Study details
- Sponsor
- University of Missouri-Columbia
- Conditions
- Postinduction Hypotension · Hypotension During Surgery
- Enrolling
- 100 people
- Starts
- 2025-07-14
- Est. completion
- 2026-12
- Design
- Open-label, non-randomized, parallel groups, Phase 4
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Age ≥ 18 years old.
- Undergoing elective cystoscopy surgery as the primary procedure.
- Able to provide informed consent.
You can't join if
- Emergency surgeries.
- Past history of amputations of any body part.
- Allergies or contraindications to any medications used in the protocol or lactated ringers.
- Systolic heart failure with LVEF < 30% within the last year.
- Severely depressed RV function within the last year.
- Restrictive diastolic dysfunction within the last year.
- Currently pregnant.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openUniversity Hospital
Columbia, Missouri, United States
Study team
Sponsor
University of Missouri-Columbia
Study ID 2126906
Principal investigator
Sagar Bansal, MD
University of Missouri-Columbia
Have questions? The record lists no central contact. Use Consider me and the site team can reach you, or find them through ClinicalTrials.gov ↗.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.